{"DataElement":{"publicId":"8178610","version":"1","preferredName":"Biospecimen Events Domain Timepoint Sponsor Defined Name","preferredDefinition":"The reporting periods for which the STMF is being completed.","longName":"BETPT_SPD","context":"PMI","contextVersion":"1","DataElementConcept":{"publicId":"8178485","version":"1","preferredName":"Biospecimen Events Domain Timepoint","preferredDefinition":"An events domain that documents biospecimen collection and storage information._A specific point in the time continuum, including those established relative to an event.","longName":"6983057v1.0:2661790v1.0","context":"PMI","contextVersion":"1","ObjectClass":{"publicId":"6983057","version":"1","preferredName":"Biospecimen Events Domain","preferredDefinition":"An events domain that documents biospecimen collection and storage information.","longName":"C111138","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen Events Domain","conceptCode":"C111138","definition":"An events domain that documents biospecimen collection and storage information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E41BF3-F82C-2CB7-E053-F662850A84C2","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-14","modifiedBy":"ONEDATA","dateModified":"2019-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2661790","version":"1","preferredName":"Timepoint","preferredDefinition":"A specific point in the time continuum, including those established relative to an event.","longName":"C68568","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"345BF7BD-4636-3CED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-07-03","modifiedBy":"ONEDATA","dateModified":"2007-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PMI CDISC Harmonization","workflowStatus":"DRAFT NEW","registrationStatus":"Qualified","id":"DDCB2665-A725-0708-E053-4EBD850AE7CA","latestVersionIndicator":"Yes","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"ONEDATA","dateModified":"2022-04-29","changeDescription":"PMI CDISC STMF; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"8178489","version":"1","preferredName":"Timepoint Clinical Study Sponsor Defined Name","preferredDefinition":"A specific point in the time continuum, including those established relative to an event._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._The words or language units by which a thing is known.","longName":"TPT_SPD","context":"PMI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"3126125","version":"1","preferredName":"Other","longName":"3126125","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-814A-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":"2023.3.7 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDCB6152-1AAA-0705-E053-4EBD850A6332","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"ONEDATA","dateModified":"2022-04-29","deletedIndicator":"No"},{"value":"MRD assessment","valueDescription":"Minimal Residual Disease Assessment","ValueMeaning":{"publicId":"8178490","version":"1","preferredName":"Minimal Residual Disease Assessment","longName":"8178490","preferredDefinition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.: The final result of a determination of the value, significance, or extent of.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDCB6152-1AB4-0705-E053-4EBD850A6332","latestVersionIndicator":"Yes","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"ZHWENDY","dateModified":"2022-05-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDCB6152-1ACD-0705-E053-4EBD850A6332","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"ZHWENDY","dateModified":"2022-05-05","deletedIndicator":"No"},{"value":"Progression","valueDescription":"Disease Progression","ValueMeaning":{"publicId":"2816916","version":"1","preferredName":"Disease Progression","longName":"2816916","preferredDefinition":"The worsening of a disease over time","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E58029E-1D6F-C9CD-E040-BB89A643215D","latestVersionIndicator":"Yes","beginDate":"2008-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-12-18","modifiedBy":"TSESU","dateModified":"2022-12-28","changeDescription":"Updated VM definitions to reflect change in NCIt concept definition. mc 10/31/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDCB6152-1AD7-0705-E053-4EBD850A6332","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"ZHWENDY","dateModified":"2022-05-05","deletedIndicator":"No"},{"value":"Pre-enrollment/diagnosis","valueDescription":"Pre-enrollment Diagnosis","ValueMeaning":{"publicId":"8178491","version":"1","preferredName":"Pre-enrollment Diagnosis","longName":"8178491","preferredDefinition":"The period prior to enrollment.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pre-enrollment","conceptCode":"C187071","definition":"The period prior to enrollment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDCB6152-1AE5-0705-E053-4EBD850A6332","latestVersionIndicator":"Yes","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"ZHWENDY","dateModified":"2022-05-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDCB6152-1AFE-0705-E053-4EBD850A6332","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"ONEDATA","dateModified":"2022-04-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"8178609","version":"1","preferredName":"Timepoint Clinical Study Sponsor Defined Name","preferredDefinition":"A specific point in the time continuum, including those established relative to an event.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:The words or language units by which a thing is known.","longName":"C68568:C70793:C165683:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDCB6152-1B15-0705-E053-4EBD850A6332","latestVersionIndicator":"Yes","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"ONEDATA","dateModified":"2022-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PMI CDISC Harmonization","workflowStatus":"DRAFT NEW","registrationStatus":"Qualified","id":"DDCB6152-1A94-0705-E053-4EBD850A6332","latestVersionIndicator":"Yes","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"ZHWENDY","dateModified":"2022-05-05","changeDescription":"PMI CDISC STMF; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7765162","version":"1","longName":"PMI CDISC Harmonization","context":"PMI","ClassificationSchemeItems":[{"publicId":"8176711","version":"1","longName":"PMI CDISC STMF","context":"PMI"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Collection event name","type":"Preferred Question Text","description":"Collection event name","url":null,"context":"PMI"}],"origin":"PMI CDISC Harmonization","workflowStatus":"DRAFT NEW","registrationStatus":"Qualified","id":"DDCD4B0F-7F6E-1ED4-E053-4EBD850A7667","latestVersionIndicator":"Yes","beginDate":"2022-04-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-29","modifiedBy":"TTAYLOR","dateModified":"2022-05-02","changeDescription":"PMI CDISC STMF; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}